Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've just moved up to the 0.5mg dose of Wegovy, and something feels different — maybe your stomach is more unsettled than it was at 0.25mg, or you're wondering whether what you're feeling is normal. Side effects of Wegovy 0.5mg are real, common, and in most cases manageable; they tend to be gut-led and are typically at their most noticeable in the first week or two after a dose increase. Wegovy (semaglutide) is a prescription-only GLP-1 medicine licensed in the UK for weight management, and every dose step is assessed by a clinician for exactly this reason. The information below is drawn from the NHS semaglutide medicines page and the Wegovy SmPC; it covers what the evidence shows, what warrants a call to a doctor, and how to tell the difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
At 0.25mg, semaglutide sits at a dose low enough that most people notice relatively little. The 0.25mg pen exists to let your gut acclimatise, not to produce meaningful appetite change. Moving to 0.5mg is the first genuine step up, and for some people it's the first time Wegovy side effects become noticeable at all, which is worth bearing in mind if you've already read about what side effects the 0.25mg dose tends to bring.
The mechanism is straightforward. Semaglutide slows the rate at which food leaves the stomach. At a higher dose, that effect is stronger. Food stays longer, gastric pressure builds, and the result is nausea, burping, fullness that outlasts the meal, or an urge to eat far less than usual. Some people also notice loose stools or constipation, mild reflux, or a general feeling of low-grade fatigue in the first few days after injecting. These are consistent with what the NHS reports for semaglutide across the dose schedule.
For context on how side effects typically shift as the titration continues, our overview of moving from 0.25mg to 0.5mg covers that transitional window in detail. None of this is a reason to stop, but it is useful to know what's coming so it doesn't catch you off guard.
Timing matters too. The injection is given once weekly, and side effects tend to peak roughly 24–72 hours after the dose. If you're planning your week, some people find it useful to inject on a day when they can rest a little more the following day.
The most commonly reported 0.5mg Wegovy side effects are nausea, diarrhoea, constipation and indigestion. Less frequently, people experience vomiting, headache, dizziness, or tiredness. Injection-site reactions (mild redness or tenderness) are also possible, though rarely troublesome at this dose.
A few things that many people find genuinely useful: eating smaller portions and stopping well before you feel full, since the medicine slows your stomach's emptying and overeating on top of that amplifies nausea considerably. Avoiding very fatty or spicy meals in the days around your injection can also reduce gut discomfort. Staying well hydrated matters throughout, particularly if loose stools are a feature.
Fatigue and mild headaches usually settle within the first fortnight. If you're curious how the side effect picture changes further up the schedule, our page on side effects at the 1mg dose gives a useful forward reference, though there's no need to rush ahead.
It's also worth remembering that most people do get through the 0.5mg stage without any side effects that disrupt daily life. The titration schedule exists precisely because slower increases mean a smoother adjustment. Staying on the same dose a little longer, if needed, is a conversation for your prescriber, not a decision to make alone.
Most 0.5mg Wegovy side effects are uncomfortable rather than dangerous. But a few symptoms should prompt same-day medical attention, not a wait-and-see approach.
Severe, persistent stomach pain (especially pain that radiates toward the back) can be a sign of acute pancreatitis, a serious but infrequent risk the MHRA highlighted formally in a Drug Safety Update for GLP-1 medicines in January 2026. This is not the kind of pain to manage with antacids. If you experience it, stop your injection and seek urgent care.
Other symptoms requiring prompt medical review: vomiting or diarrhoea that is so persistent you cannot keep fluids down (dehydration can develop quickly and strain the kidneys); signs of an allergic reaction such as facial swelling, difficulty breathing or a spreading rash; symptoms of gallbladder problems such as sharp pain in the upper right abdomen, fever and yellowing skin or eyes.
Contact your prescriber or GP for anything that worries you. If you're unsure, calling 111 is entirely appropriate. You can also report any suspected side effects (including ones that feel minor but persistent) through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. Patient reports genuinely shape how these medicines are monitored in the UK.
If you're reading this because you're weighing up whether to proceed with Wegovy treatment or thinking about where to get it assessed properly, it's worth knowing how a regulated private service handles this part of the journey. Wegovy is a prescription-only medicine; the dose schedule is not self-directed. Every increase (including the step to 0.5mg) requires a clinical review, not just a refill.
At nume, a GPhC-registered Independent Prescriber reads your consultation before every order. That review covers side effects you've experienced, any new health changes, and whether the current dose is working as expected. If something in your history suggests the 0.5mg increase carries elevated risk, the prescriber says so. Our clinical team can discuss any aspect of your suitability and side-effect profile as part of that consultation, it's not a box-tick, it's the whole point.
You can explore how the full dosing schedule is structured on our Wegovy doses page, and if you want to understand what the side effect picture looks like at the other end of the titration, our guide to side effects at the 2.4mg maintenance dose is worth reading ahead of time. When you're ready to start or continue treatment through a regulated pharmacy, a free consultation is the place to begin. Semaglutide carries a Black Triangle (▼) status with the MHRA, meaning it remains under additional monitoring, another reason clinical oversight at every step matters.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.